Chemours Co. (CC)

24.78
0.22 0.88
NYSE
Prev Close 25.00
Open 25.05
Day Low/High 24.65 / 25.48
52 Wk Low/High 7.02 / 26.07
Volume 377.30K
Exchange NYSE
Shares Outstanding 164.50B
Market Cap 4.11B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Renewed Life for the Tax Loss Selling Recovery Portfolio

Renewed Life for the Tax Loss Selling Recovery Portfolio

The idea behind this annual 'experiment' is to identify potentially 'cheap' names with 3 attributes.

Updating My Annual Tax Loss Selling Recovery Portfolio

Updating My Annual Tax Loss Selling Recovery Portfolio

There's progress for sure, but still a long way to go. Things could be worse.

This Year's Tax-Loss-Selling Recovery Portfolio Is a Real Loser So Far

This Year's Tax-Loss-Selling Recovery Portfolio Is a Real Loser So Far

This experiment in trying to identify stocks that could come back after dismal year-ago performance isn't going well five months since its inception.

Jim Cramer: Oil Tanked, and We're in Uncharted Waters

Jim Cramer: Oil Tanked, and We're in Uncharted Waters

Oil isn't really worthless and Amazon isn't the only retailer that will survive, but we are in a mixed up market thanks to Covid-19.

How We Doing? My 12 Potential Tax-Loss Selling Candidates

How We Doing? My 12 Potential Tax-Loss Selling Candidates

If investors reengage with these names in 2020, this could be an interesting set-up for market outperformance.

My Tax-Loss Selling Year-End Portfolio

My Tax-Loss Selling Year-End Portfolio

In this portfolio, the goal is for the winners to more than offset the losers.

The Final 4 Unsightly Stocks Going Into My Next Tax-Loss Selling Portfolio

The Final 4 Unsightly Stocks Going Into My Next Tax-Loss Selling Portfolio

We'll track a dozen beaten-up stocks that could be subject to tax-loss selling at the end of 2019 to see whether they can stage comebacks in 2020.

This Chemical Stock Has the Formula for a Bullish Reversal

This Chemical Stock Has the Formula for a Bullish Reversal

At the very end of December, the shorter of the two downtrend lines was violated suggesting a possible reversal at hand.

2 Beaten-Down Big-Caps for Value Shoppers

2 Beaten-Down Big-Caps for Value Shoppers

Kraft Heinz and DowDuPont spinoff Chemours offer attractive dividends and value potential.

Chemours Finally Has the Right Mix

Chemours Finally Has the Right Mix

The long correction in the chemicals company is over and traders can now go long on strength.

Make Some Bucks with Buckeye?

Make Some Bucks with Buckeye?

Beaten down pipeline MLP offers an attractive reward vs. risk profile.

'Lock and Roll' on Chemours

'Lock and Roll' on Chemours

We'll roll our CC profits into a November call spread.

Chemours Has the Right Chemistry

Chemours Has the Right Chemistry

The stock has been having a good year, but it's breaking out higher today.

Sometimes You Crave 'Junk Food' -- Even When Investing

Sometimes You Crave 'Junk Food' -- Even When Investing

At Libbey, the glass may be half empty, but it's likely to fill up again.

Sometimes You Crave 'Junk Food'

Sometimes You Crave 'Junk Food'

At Libbey, the glass may be half empty, but it's likely to fill up again.

These Stocks Have Changed Direction

These Stocks Have Changed Direction

Finding bullish and bearish reversals in the market.

Cramer: Are You Paying Attention to These Boring Companies? You Should

Cramer: Are You Paying Attention to These Boring Companies? You Should

We ought to open our eyes to what we don't care about, to what's still made here.

Chemours upgraded at Jefferies

Chemours: My Chemical/Technical Romance

Chemours: My Chemical/Technical Romance

CC has made a strong upside move but more gains are anticipated in the weeks ahead.

'Higher Value' Chemistry Key to Turnaround Says Chemours CEO

'Higher Value' Chemistry Key to Turnaround Says Chemours CEO

Chemours is up over 153% year-to-date and more than 50% since a short-seller targeted the chemical maker.

Anything These Guys Are Selling, I'm not Buying

Anything These Guys Are Selling, I'm not Buying

When KKR and Apollo sell a stock it should be a huge red flag to investors to consider following suit.

Closing Bell: Chemours Spikes on Jury Verdict; U.S. Stocks Rally

Closing Bell: Chemours Spikes on Jury Verdict; U.S. Stocks Rally

Wall Street closed out the holiday-shortened week with a bang.

Cramer: Amazon Hits All-Time High Without Retail Folding

And that's distinctly good news for the overall market.

Here’s Short-Seller Andrew Left’s Latest Target

Here’s Short-Seller Andrew Left’s Latest Target

Shares of Chemours plunged on Friday on the heels of a bearish report written by short-seller Andrew Left of Citron Research.

Trending Tickers: SBUX , CC, BAC, ETFC, DNKN

Trending Tickers: SBUX , CC, BAC, ETFC, DNKN

U.S. markets falter Friday after an especially weak jobs report. 

Short-Seller Cites 'Evil' of DuPont Spinoff Chemours

Short-Seller Cites 'Evil' of DuPont Spinoff Chemours

Andrew Left says he feels 'guilty' bringing up the stock issue when the humanitarian issue is much bigger.